Replies to post #317 on Viking Therapeutics Inc (VKTX)

[greens12]

Cant believe how oversold it is, The Phase 2 trials are almost done.

Any thought on why MDGL is trading at a 12 X multiple at 16.00... while VKTX with a better pipeline at 1.14 has a better lipid drug in Phase 2 report and a potential blockbuster drug VK5211 phase 2 data coming both in the second half of 2017 ?